Testosterone for the aging male; current evidence and recommended practice

References

• [AHA] American Heart AssociationHeart disease and stroke statistics2002DallasAmerican Heart Association
   Google Scholar
• AlmeidaOPWaterreusASpryNOne year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in menPsychoneuroendocrinology20042910718115219659
   PubMed Web of Science ®Google Scholar
• AminorroayaAKelleherSConwayAJAdequacy of androgen replacement influences bone density response to testosterone in androgen-deficient menEur J Endocrinol2005152881615941928
   PubMed Web of Science ®Google Scholar
• AmoryJKWattsNBEasleyKAExogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosteroneJ Clin Endocrinol Metab2004895031014764753
   PubMed Web of Science ®Google Scholar
• AndersonRALudlamCAWuFCHaemostatic effects of supraphysiological levels of testosterone in normal menThromb Haemost19957469378585008
   PubMed Web of Science ®Google Scholar
• AnderssonBMarinPLissnerLTestosterone concentrations in women and men with NIDDMDiabetes Care199417405118062607
   PubMed Web of Science ®Google Scholar
• AversaAIsidoriAMSperaGAndrogens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunctionClin Endocrinol (Oxf)200358632812699447
   PubMed Web of Science ®Google Scholar
• AzadNPitaleSBarnesWETestosterone treatment enhances regional brain perfusion in hypogonadal menJ Clin Endocrinol Metab2003883064812843144
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorELower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitusAnn Intern Med1992117807111416554
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEGoodman-GruenDPatayBEndogenous sex hormones and cognitive function in older menJ Clin Endocrinol Metab1999843681510523014
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEKhawKTEndogenous sex hormones and cardiovascular disease in men. A prospective population-based studyCirculation198878539453409497
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEVon MuhlenDGKritz-SilversteinDBioavailable testosterone and depressed mood in older men: the Rancho Bernardo StudyJ Clin Endocrinol Metab199984573710022418
   PubMed Web of Science ®Google Scholar
• BaumgartnerRNWatersDLGallagherDPredictors of skeletal muscle mass in elderly men and womenMech Ageing Dev19991071233610220041
   PubMed Web of Science ®Google Scholar
• BehreHMKlieschSLeifkeELong-term effect of testosterone therapy on bone mineral density in hypogonadal menJ Clin Endocrinol Metab1997822386909253305
   PubMed Web of Science ®Google Scholar
• BehreHMvon EckardsteinSKlieschSLong-term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 yearsClin Endocrinol (Oxf)1999506293510468929
   PubMed Web of Science ®Google Scholar
• BenitoMVasilicBWehrliFWEffect of testosterone replacement on trabecular architecture in hypogonadal menJ Bone Miner Res20052017859116160736
   PubMed Web of Science ®Google Scholar
• BhasinSWoodhouseLCasaburiRTestosterone dose-response relationships in healthy young menAm J Physiol Endocrinol Metab2001281E11728111701431
   PubMed Web of Science ®Google Scholar
• BhasinSWoodhouseLCasaburiROlder men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscleJ Clin Endocrinol Metab2005906788815562020
   PubMed Web of Science ®Google Scholar
• BjorntorpPThe regulation of adipose tissue distribution in humansInt J Obes Relat Metab Disord1996202913028680455
   PubMed Web of Science ®Google Scholar
• Bonithon-KoppCScarabinPYBaraLRelationship between sex hormones and haemostatic factors in healthy middle-aged menAtherosclerosis1988717163377881
   PubMed Web of Science ®Google Scholar
• BoyanovMABonevaZChristovVGTestosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiencyAging Male200361712809074
   PubMedGoogle Scholar
• BuenaFSwerdloffRSSteinerBSSexual function does not change when serum testosterone levels are pharmacologically varied within the normal male rangeFertil Steril1993591118238486184
   PubMed Web of Science ®Google Scholar
• CampionJMMaricicMJOsteoporosis in menAm Fam Physician2003671521612722852
   PubMed Web of Science ®Google Scholar
• CaraniCQinKSimoniMEffect of testosterone and estradiol in a man with aromatase deficiencyN Engl J Med19973379159211678
   PubMed Web of Science ®Google Scholar
• CarterHBPearsonJDMetterEJLongitudinal evaluation of serum androgen levels in men with and without prostate cancerProstate19952725317541528
   PubMed Web of Science ®Google Scholar
• ChangKPCenterJRNguyenTVIncidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology StudyJ Bone Miner Res200419532615005838
   PubMed Web of Science ®Google Scholar
• CherrierMMAsthanaSPlymateSTestosterone supplementation improves spatial and verbal memory in healthy older menNeurology20015780811445632
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJKThe role of aromatization in testosterone supplementation: effects on cognition in older menNeurology2005a64290615668427
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJKTestosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairmentNeurology2005b642063815985573
   PubMed Web of Science ®Google Scholar
• CohenPGThe hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt – a major factor in the genesis of morbid obesityMed Hypotheses199952495110342671
   PubMed Web of Science ®Google Scholar
• CorralesJJBurgoRMGarca-BerrocalBPartial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic controlMetabolism2004536667215131775
   PubMed Web of Science ®Google Scholar
• De PergolaGDe MitrioVSciaraffiaMLower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in menMetabolism1997461287939361687
   PubMed Web of Science ®Google Scholar
• De PergolaGPannacciulliNCicconeMFree testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult menInt J Obes Relat Metab Disord200327803712821965
   PubMed Web of Science ®Google Scholar
• DhindsaSPrabhakarSSethiMFrequent occurrence of hypogonadotropic hypogonadism in type 2 diabetesJ Clin Endocrinol Metab2004895462815531498
   PubMed Web of Science ®Google Scholar
• DiverMJImtiazKEAhmadAMDiurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young menClin Endocrinol (oxf)2003587101712780747
   PubMed Web of Science ®Google Scholar
• DunnJFNisulaBCRodbardDTransport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasmaJ Clin Endocrinol Metab19815358687195404
   PubMed Web of Science ®Google Scholar
• EnglishKMSteedsRPJonesTHLow-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled studyCirculation200010219061111034937
   PubMed Web of Science ®Google Scholar
• FeldmanHALongcopeCDerbyCAAge trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging studyJ Clin Endocrinol Metab2002875899811836290
   PubMed Web of Science ®Google Scholar
• FerrandoAASheffield-MooreMYeckelCWTestosterone administration to older men improves muscle function: molecular and physiological mechanismsAm J Physiol Endocrinol Metab2002282E601711832363
   PubMed Web of Science ®Google Scholar
• FinkelsteinJWSusmanEJChinchilliVMEstrogen or testosterone increases self-reported aggressive behaviors in hypogonadal adolescentsJ Clin Endocrinol Metab199782243389253313
   PubMed Web of Science ®Google Scholar
• FogariRPretiPZoppiASerum testosterone levels and arterial blood pressure in the elderlyHypertens Res2005286253016392765
   PubMed Web of Science ®Google Scholar
• FukuiMKitagawaYNakamuraNAssociation between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetesDiabetes Care20032618697312766125
   PubMed Web of Science ®Google Scholar
• GallonCVeyssiereGBergerMAge-related changes in the concentration of cytosolic androgen receptors in the epididymis, vas deferens and seminal vesicle of maturing male miceJ Androl198910188942745231
   PubMedGoogle Scholar
• GandySAlmeidaOPFonteJChemical andropause and amyloid-beta peptideJAMA20012852195611325319
   PubMed Web of Science ®Google Scholar
• GannPHHennekensCHLongcopeCA prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasiaProstate1995264097531326
   PubMed Web of Science ®Google Scholar
• GaylisFDLinDWIgnatoffJMProstate cancer in men using testosterone supplementationJ Urol20051745348 discussion 53816006887
   PubMed Web of Science ®Google Scholar
• GlueckCJGlueckHIStroopDEndogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic menJ Lab Clin Med1993122412208228555
   PubMed Web of Science ®Google Scholar
• GoreJRajferJThe role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunctionRev Urol200462071016985604
   PubMedGoogle Scholar
• GrayPBSinghABWoodhouseLJDose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older menJ Clin Endocrinol Metab20059038384615827094
   PubMed Web of Science ®Google Scholar
• HaffnerSMMykkanenLValdezRARelationship of sex hormones to lipids and lipoproteins in nondiabetic menJ Clin Endocrinol Metab1993771610158263149
   PubMed Web of Science ®Google Scholar
• HaffnerSMShatenJSternMPLow levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention TrialAm J Epidemiol1996143889978610702
   PubMed Web of Science ®Google Scholar
• HaffnerSMValdezRAMykkanenLDecreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic menMetabolism1994435996038177048
   PubMed Web of Science ®Google Scholar
• HakAEWittemanJCde JongFHLow levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam studyJ Clin Endocrinol Metab2002873632912161487
   PubMed Web of Science ®Google Scholar
• HallJJonesRDJonesTHSelective inhibition of L-type Ca2+channels in A7r5 cells by physiological levels of testosteroneEndocrinology200614726758016527846
   PubMed Web of Science ®Google Scholar
• HandelsmanDJMackeyMAHoweCAn analysis of testosterone implants for androgen replacement therapyClin Endocrinol (Oxf)199747311169373452
   PubMed Web of Science ®Google Scholar
• HarmanSMMetterEJTobinJDLongitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of AgingJ Clin Endocrinol Metab2001867243111158037
   PubMed Web of Science ®Google Scholar
• HeikkilaRAhoKHeliovaaraMSerum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal studyCancer1999863121510421267
   PubMed Web of Science ®Google Scholar
• HirshkowitzMMooreCAO’ConnorSAndrogen and sleep-related erectionsJ Psychosom Res19974254169226601
   PubMed Web of Science ®Google Scholar
• HolundBLatent prostatic cancer in a consecutive autopsy seriesScand J Urol Nephrol19801429356154966
   PubMed Web of Science ®Google Scholar
• HsingAWChokkalingamAPGaoYTPolymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control studyCancer Epidemiol Biomarkers Prev2002113374111927493
   PubMed Web of Science ®Google Scholar
• HsingAWGaoYTWuGPolymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in ChinaCancer Res20006051111611016637
   PubMed Web of Science ®Google Scholar
• ImamotoTSuzukiHFukasawaSPretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomyEur Urol2005473081215716191
   PubMed Web of Science ®Google Scholar
• IsidoriAMGiannettaEGrecoEAEffects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysisClin Endocrinol (Oxf)2005632809316117815
   PubMed Web of Science ®Google Scholar
• Isom-BatzGBiancoFJJrKattanMWTestosterone as a predictor of pathological stage in clinically localized prostate cancerJ Urol20051731935715879785
   PubMed Web of Science ®Google Scholar
• JacksonJARiggsMWSpiekermanAMTestosterone deficiency as a risk factor for hip fractures in men: a case-control studyAm J Med Sci1992304481642253
   PubMed Web of Science ®Google Scholar
• JainPRademakerAWMcVaryKTTestosterone supplementation for erectile dysfunction: results of a meta-analysisJ Urol2000164371510893588
   PubMed Web of Science ®Google Scholar
• JanowskyJSChavezBOrwollESex steroids modify working memoryJ Cogn Neurosci2000124071410931767
   PubMed Web of Science ®Google Scholar
• JanowskyJSOviattSKOrwollESTestosterone influences spatial cognition in older menBehav Neurosci1994108325328037876
   PubMed Web of Science ®Google Scholar
• JemalAMurrayTSamuelsACancer statistics, 2003CA Cancer J Clin20035352612568441
   PubMed Web of Science ®Google Scholar
• JonesRDNettleshipJEKapoorDTestosterone and atherosclerosis in aging men: purported association and clinical implicationsAm J Cardiovasc Drugs200551415415901202
   PubMedGoogle Scholar
• JonesRDPughPJJonesTHThe vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?Br J Pharmacol20031387334412642373
   PubMed Web of Science ®Google Scholar
• JonesTHTestosterone associations with erectile dysfunction, diabetes and the metabolic syndromeEur Urol Suppl2007684757
   Web of Science ®Google Scholar
• JonesTHJonesRDChannerKSTestosterone and cardiovascular disordersRecent Research Developments in Endocrinology and Metabolism20031Kerala, IndiaTransworld Research Network143167
   Google Scholar
• KapoorDAldredHClarkSClinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposityDiabetes Care2007309111717392552
   PubMed Web of Science ®Google Scholar
• KapoorDClarkeSChannerKSErectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetesInt J Androl200730500718028199
   PubMed Web of Science ®Google Scholar
• KapoorDGoodwinEChannerKSTestosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetesEur J Endocrinol200615489990616728551
   PubMed Web of Science ®Google Scholar
• KapoorDMalkinCJChannerKSAndrogens, insulin resistance and vascular disease in menClin Endocrinol (Oxf)2005632395016117808
   PubMed Web of Science ®Google Scholar
• KatznelsonLFinkelsteinJSSchoenfeldDAIncrease in bone density and lean body mass during testosterone administration in men with acquired hypogonadismJ Clin Endocrinol Metab1996814358658954042
   PubMed Web of Science ®Google Scholar
• KatznelsonLRosenthalDIRosolMSUsing quantitative CT to assess adipose distribution in adult men with acquired hypogonadismAJR Am J Roentgenol199817042379456958
   PubMed Web of Science ®Google Scholar
• KennyAMBellantonioSGrumanCAEffects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levelsJ Gerontol A Biol Sci Med Sci200257M321511983727
   PubMed Web of Science ®Google Scholar
• KennyAMFabregasGSongCEffects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive lossJ Gerontol A Biol Sci Med Sci20045975814718489
   PubMed Web of Science ®Google Scholar
• KennyAMPrestwoodKMGrumanCAEffects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levelsJ Gerontol A Biol Sci Med Sci200156M2667211320105
   PubMed Web of Science ®Google Scholar
• KennyAMPrestwoodKMRaiszLGShort-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levelsEndocr Res2000261536810921445
   PubMed Web of Science ®Google Scholar
• KhawKTBarrett-ConnorEBlood pressure and endogenous testosterone in men: an inverse relationshipJ Hypertens19886329323379300
   PubMed Web of Science ®Google Scholar
• KhawKTBarrett-ConnorELower endogenous androgens predict central adiposity in menAnn Epidemiol19922675821342319
   PubMedGoogle Scholar
• KhoslaSMeltonLJ3rdAtkinsonEJRelationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly menJ Clin Endocrinol Metab20018635556111502778
   PubMed Web of Science ®Google Scholar
• KhoslaSMeltonLJ3rdAtkinsonEJRelationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogenJ Clin Endocrinol Metab1998832266749661593
   PubMed Web of Science ®Google Scholar
• KontoleonPEAnastasiou-NanaMIPapapetrouPDHormonal profile in patients with congestive heart failureInt J Cardiol2003871798312559538
   PubMed Web of Science ®Google Scholar
• KratzikCWSchatzlGLunglmayrGThe impact of age, body mass index and testosterone on erectile dysfunctionJ Urol2005174240315947646
   PubMed Web of Science ®Google Scholar
• KraussDJTaubHALantingaLJRisks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotenceJ Urol19911461566701942342
   PubMed Web of Science ®Google Scholar
• KupelianVPageSTAraujoABLow SHBG, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese menJ Clin Endocrinol Metab2006
   Web of Science ®Google Scholar
• LaaksonenDENiskanenLPunnonenKSex hormones, inflammation and the metabolic syndrome: a population-based studyEur J Endocrinol2003149601814641004
   PubMed Web of Science ®Google Scholar
• LaaksonenDENiskanenLPunnonenKTestosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged menDiabetes Care20042710364115111517
   PubMed Web of Science ®Google Scholar
• LeeCHKuoSWHungYJThe effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabeticsEndocr Res2005311394816353672
   PubMed Web of Science ®Google Scholar
• LeifkeEKornerHCLinkTMEffects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal menEur J Endocrinol19981385189461316
   PubMed Web of Science ®Google Scholar
• LeifkeEWichersCGorenoiVLow serum levels of testosterone in men with minimal traumatic hip fracturesExp Clin Endocrinol Diabetes20051132081315891956
   PubMed Web of Science ®Google Scholar
• LichtensteinMJYarnellJWElwoodPCSex hormones, insulin, lipids, and prevalent ischemic heart diseaseAm J Epidemiol1987126647573307391
   PubMed Web of Science ®Google Scholar
• LinnMCPetersenACEmergence and characterization of sex differences in spatial ability: a meta-analysisChild Dev1985561479984075870
   PubMed Web of Science ®Google Scholar
• LorentzonMSwansonCAnderssonNFree testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD studyJ Bone Miner Res20052013344116007330
   PubMed Web of Science ®Google Scholar
• LuPHMastermanDAMulnardREffects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly menArch Neurol2005
   Google Scholar
• LuboshitzkyRAvivAHefetzADecreased pituitary-gonadal secretion in men with obstructive sleep apneaJ Clin Endocrinol Metab2002873394812107256
   PubMed Web of Science ®Google Scholar
• LyLPJimenezMZhuangTNA double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiencyJ Clin Endocrinol Metab20018640788811549629
   PubMed Web of Science ®Google Scholar
• MacKayJDMensahGAThe atlas of heart disease and stroke2004GenevaWHO
   Google Scholar
• MaggioMBasariaSBleACorrelation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older menJ Clin Endocrinol Metab200691345716263825
   PubMed Web of Science ®Google Scholar
• MalkinCJPughPJJonesRDThe effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal menJ Clin Endocrinol Metab20048933131815240608
   PubMed Web of Science ®Google Scholar
• MalkinCJPughPJMorrisPDTestosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of lifeHeart200490871615253956
   PubMed Web of Science ®Google Scholar
• MalkinCJPughPJWestJNTestosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trialEur Heart J200627576416093267
   PubMed Web of Science ®Google Scholar
• MarinPHolmangSGustafssonCAndrogen treatment of abdominally obese menObes Res199312455116350577
   PubMedGoogle Scholar
• MarinPHolmangSJonssonLThe effects of testosterone treatment on body composition and metabolism in middle-aged obese menInt J Obes Relat Metab Disord19921699171335979
   PubMed Web of Science ®Google Scholar
• MarinPKrotkiewskiMBjorntorpPAndrogen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissuesEur J Med19921329361341460
   PubMedGoogle Scholar
• MarinPLonnLAnderssonBAssimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosteroneJ Clin Endocrinol Metab1996811018228772568
   PubMed Web of Science ®Google Scholar
• MarinPOdenBBjorntorpPAssimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgensJ Clin Endocrinol Metab199580239437829619
   PubMed Web of Science ®Google Scholar
• MassengillJCSunLMoulJWPretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJ Urol20031691670512686805
   PubMed Web of Science ®Google Scholar
• MatsumotoAMSandblomRESchoeneRBTestosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleepClin Endocrinol (Oxf)198522713214017261
   PubMed Web of Science ®Google Scholar
• MaurasNHayesVWelchSTestosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposityJ Clin Endocrinol Metab1998831886929626114
   PubMed Web of Science ®Google Scholar
• MoffatSDZondermanABMetterEJLongitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly menJ Clin Endocrinol Metab2002875001712414864
   PubMed Web of Science ®Google Scholar
• MoffatSDZondermanABMetterEJFree testosterone and risk for Alzheimer disease in older menNeurology2004621889314745052
   PubMed Web of Science ®Google Scholar
• MooreCHueblerDZimmermannTThe Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiencyEur Urol20044680715183551
   PubMed Web of Science ®Google Scholar
• MorgentalerABruningCO3rdDeWolfWCOccult prostate cancer in men with low serum testosterone levelsJAMA1996276190468968017
   PubMed Web of Science ®Google Scholar
• MorleyJECharltonEPatrickPValidation of a screening questionnaire for androgen deficiency in aging malesMetabolism20004912394211016912
   PubMed Web of Science ®Google Scholar
• MorleyJEPerryHM3rdKaiserFEEffects of testosterone replacement therapy in old hypogonadal males: a preliminary studyJ Am Geriatr Soc199341149528426037
   PubMed Web of Science ®Google Scholar
• MorrisPDMalkinCJChannerKSA mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 menEur J Endocrinol2004151241915296480
   PubMed Web of Science ®Google Scholar
• MullerMGrobbeeDEden TonkelaarIEndogenous sex hormones and metabolic syndrome in aging menJ Clin Endocrinol Metab20059026182315687322
   PubMed Web of Science ®Google Scholar
• MullerMvan den BeldAWBotsMLEndogenous sex hormones and progression of carotid atherosclerosis in elderly menCirculation20041092074915096452
   PubMed Web of Science ®Google Scholar
• MulliganTIranmaneshAKerznerRTwo-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axisEur J Endocrinol19991412576610474123
   PubMed Web of Science ®Google Scholar
• MulliganTIranmaneshAVeldhuisJDPulsatile iv infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the aging maleJ Clin Endocrinol Metab20018655475311701734
   PubMed Web of Science ®Google Scholar
• MurakamiSOtsukaKHottaNCommon carotid intima-media thickness is predictive of all-cause and cardiovascular mortality in elderly community-dwelling people: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) studyBiomed Pharmacother200559Suppl 1S495316275507
   PubMed Web of Science ®Google Scholar
• MurphySKhawKTCassidyASex hormones and bone mineral density in elderly menBone Miner199320133408453329
   PubMedGoogle Scholar
• NCEPIIIExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
   PubMed Web of Science ®Google Scholar
• NieschlagEBehreHMBouchardPTestosterone replacement therapy: current trends and future directionsHum Reprod Update2004104091915297434
   PubMed Web of Science ®Google Scholar
• NieschlagECuppersHJWiegelmannWBioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal menHorm Res19767138451002121
   PubMed Web of Science ®Google Scholar
• NieschlagESwerdloffRBehreHMInvestigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendationsInt J Androl200528125715910536
   PubMed Web of Science ®Google Scholar
• NoirhommePJacquetLUnderwoodMThe effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failureEur J Cardiothorac Surg19991663710456405
   PubMed Web of Science ®Google Scholar
• O’ConnorDBArcherJHairWMExogenous testosterone, aggression, and mood in eugonadal and hypogonadal menPhysiol Behav2002755576612062320
   PubMed Web of Science ®Google Scholar
• OhJYBarrett-ConnorEWedickNMEndogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo studyDiabetes Care200225556011772901
   PubMed Web of Science ®Google Scholar
• OngphiphadhanakulBRajatanavinRChailurkitLSerum testosterone and its relation to bone mineral density and body composition in normal malesClin Endocrinol (Oxf)199543727338736276
   PubMed Web of Science ®Google Scholar
• OnoKHajiMNawataHAge-related changes in glucocorticoid and androgen receptors of cultured human pubic skin fibroblastsGerontology198834128333262075
   PubMed Web of Science ®Google Scholar
• PageSTAmoryJKBowmanFDExogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum TJ Clin Endocrinol Metab20059015021015572415
   PubMed Web of Science ®Google Scholar
• PariharMSHemnaniTAlzheimer’s disease pathogenesis and therapeutic interventionsJ Clin Neurosci2004114566715177383
   PubMed Web of Science ®Google Scholar
• ParkerSArmitageMExperience with transdermal testosterone replacement therapy for hypogonadal menClin Endocrinol (Oxf)199950576210341856
   PubMed Web of Science ®Google Scholar
• ParsonsJKCarterHBPlatzEASerum testosterone and the risk of prostate cancer: potential implications for testosterone therapyCancer Epidemiol Biomarkers Prev20051422576016172240
   PubMed Web of Science ®Google Scholar
• PerryPJAndersenKHYatesWRIllicit anabolic steroid use in athletes. A case series analysisAm J Sports Med19901842282403192
   PubMed Web of Science ®Google Scholar
• PhillipsGBRelationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesityMetabolism199342116208446038
   PubMed Web of Science ®Google Scholar
• PhillipsGBJingTHeymsfieldSBRelationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarctionMetabolism2003527849012800107
   PubMed Web of Science ®Google Scholar
• PhillipsGBJingTYResnickLMSex hormones and hemostatic risk factors for coronary heart disease in men with hypertensionJ Hypertens1993116997028228187
   PubMed Web of Science ®Google Scholar
• PikeCJTestosterone attenuates beta-amyloid toxicity in cultured hippocampal neuronsBrain Res2001919160511689174
   PubMed Web of Science ®Google Scholar
• PincusSMVeldhuisJDMulliganTEffects of age on the irregularity of LH and FSH serum concentrations in women and menAm J Physiol1997273E989959374686
   PubMed Web of Science ®Google Scholar
• PonholzerATemmlCMockKPrevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaireEur Urol200547805 discussion 85–615582253
   PubMed Web of Science ®Google Scholar
• PopeHGJrCohaneGHKanayamaGTestosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trialAm J Psychiatry20031601051112505808
   PubMed Web of Science ®Google Scholar
• PouliotWAHandaRJBeckSGAndrogen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cellsSynapse19962310198723131
   PubMed Web of Science ®Google Scholar
• PughPJJonesRDWestJNTestosterone treatment for men with chronic heart failureHeart200490446715020527
   PubMed Web of Science ®Google Scholar
• PughPJJonesTHChannerKSAcute haemodynamic effects of testosterone in men with chronic heart failureEur Heart J2003249091512714022
   PubMed Web of Science ®Google Scholar
• Rebuffe-ScriveMMarinPBjorntorpPEffect of testosterone on abdominal adipose tissue in menInt J Obes19911579151778664
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerARisks of testosterone-replacement therapy and recommendations for monitoringN Engl J Med20043504829214749457
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerAInfluence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapyInt J Impot Res2005
   Google Scholar
• RhodenELRibeiroEPTelokenCDiabetes mellitus is associated with subnormal serum levels of free testosterone in menBJU Int2005968677016153219
   PubMed Web of Science ®Google Scholar
• RhodenELTelokenCMafessoniRIs there any relation between serum levels of total testosterone and the severity of erectile dysfunction?Int J Impot Res2002141677112058243
   PubMed Web of Science ®Google Scholar
• RosanoGMLeonardoFPagnottaPAcute anti-ischemic effect of testosterone in men with coronary artery diseaseCirculation19999916667010190874
   PubMed Web of Science ®Google Scholar
• RossRJJabbarAJonesTHPharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal menEur J Endocrinol2004150576314713280
   PubMed Web of Science ®Google Scholar
• RoyTABlackmanMRHarmanSMInterrelationships of serum testosterone and free testosterone index with FFM and strength in aging menAm J Physiol Endocrinol Metab2002283E2849412110533
   PubMed Web of Science ®Google Scholar
• RuckerDEzzatSDiamandiAIGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling menClin Endocrinol (Oxf)200460491915049965
   PubMed Web of Science ®Google Scholar
• SalminenEKPortinRIKoskinenAAssociations between serum testosterone fall and cognitive function in prostate cancer patientsClin Cancer Res20041075758215569988
   PubMed Web of Science ®Google Scholar
• SchubertMMinnemannTHublerDIntramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadismJ Clin Endocrinol Metab20048954293415531493
   PubMed Web of Science ®Google Scholar
• SchurmeyerTWickingsEJFreischemCWSaliva and serum testosterone following oral testosterone undecanoate administration in normal and hypogonadal menActa Endocrinol (Copenh)1983102456626402875
   PubMedGoogle Scholar
• ScopacasaFWishartJMNeedAGBone density and bone-related biochemical variables in normal men: a longitudinal studyJ Gerontol A Biol Sci Med Sci200257M3859112023268
   PubMed Web of Science ®Google Scholar
• ScraggJLJonesRDChannerKSTestosterone is a potent inhibitor of L-type Ca(2+) channelsBiochem Biophys Res Commun2004318503615120629
   PubMed Web of Science ®Google Scholar
• SeidmanSNSpatzERizzoCTestosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trialJ Clin Psychiatry2001624061211465516
   PubMed Web of Science ®Google Scholar
• ShabsighRTestosterone therapy in erectile dysfunction and hypogonadismJ Sex Med200527859216422803
   PubMed Web of Science ®Google Scholar
• ShabsighRAnastasiadisAGErectile dysfunctionAnnu Rev Med2003541536812525671
   PubMed Web of Science ®Google Scholar
• ShabsighRKaufmanJMSteidleCRandomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil aloneJ Urol20041726586315247755
   PubMed Web of Science ®Google Scholar
• SihRMorleyJEKaiserFETestosterone replacement in older hypogonadal men: a 12-month randomized controlled trialJ Clin Endocrinol Metab199782166179177359
   PubMed Web of Science ®Google Scholar
• SimonDPreziosiPBarrett-ConnorEInterrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom StudyDiabetologia19923517371547923
   PubMed Web of Science ®Google Scholar
• SkakkebaekNEBancroftJDavidsonDWAndrogen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled studyClin Endocrinol (Oxf)19811449617014044
   PubMed Web of Science ®Google Scholar
• SmithAMEnglishKMMalkinCJTestosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable anginaEur J Endocrinol20051522859115745938
   PubMed Web of Science ®Google Scholar
• SmithEPBoydJFrankGREstrogen resistance caused by a mutation in the estrogen-receptor gene in a manN Engl J Med19943311056618090165
   PubMed Web of Science ®Google Scholar
• SmithJCBennettSEvansLMThe effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancerJ Clin Endocrinol Metab2001864261711549659
   PubMed Web of Science ®Google Scholar
• SnyderPJPeacheyHBerlinJAEffects of testosterone replacement in hypogonadal menJ Clin Endocrinol Metab2000852670710946864
   PubMed Web of Science ®Google Scholar
• SnyderPJPeacheyHHannoushPEffect of testosterone treatment on bone mineral density in men over 65 years of ageJ Clin Endocrinol Metab19998419667210372695
   PubMed Web of Science ®Google Scholar
• SorvaRKuusiTTaskinenMRTestosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal malesAtherosclerosis19886919173126749
   PubMed Web of Science ®Google Scholar
• StattinPLummeSTenkanenLHigh levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective studyInt J Cancer20041084182414648709
   PubMed Web of Science ®Google Scholar
• SteidleCSchwartzSJacobyKAA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual functionJ Clin Endocrinol Metab20038826738112788872
   PubMed Web of Science ®Google Scholar
• StellatoRKFeldmanHAHamdyOTestosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging studyDiabetes Care200023490410857940
   PubMed Web of Science ®Google Scholar
• StorerTWMaglianoLWoodhouseLTestosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tensionJ Clin Endocrinol Metab20038814788512679426
   PubMed Web of Science ®Google Scholar
• SvartbergJvon MuhlenDSchirmerHAssociation of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso StudyEur J Endocrinol20041501657114713281
   PubMed Web of Science ®Google Scholar
• SvartbergJvon MuhlenDSundsfjordJWaist circumference and testosterone levels in community dwelling men. The Tromso studyEur J Epidemiol2004196576315461197
   PubMed Web of Science ®Google Scholar
• SwerdloffRSWangCCunninghamGLong-term pharmacokinetics of transdermal testosterone gel in hypogonadal menJ Clin Endocrinol Metab20008545001011134099
   PubMed Web of Science ®Google Scholar
• TanRSPuSJA pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s diseaseAging Male20036131712809076
   PubMedGoogle Scholar
• TapplerBKatzMPituitary-gonadal dysfunction in low-output cardiac failureClin Endocrinol (Oxf)19791021926455737
   PubMed Web of Science ®Google Scholar
• Tena-SempereMPinillaLGonzalezLCLeptin inhibits testosterone secretion from adult rat testis in vitroJ Endocrinol19991612111810320818
   PubMed Web of Science ®Google Scholar
• TenoverJSEffects of testosterone supplementation in the aging maleJ Clin Endocrinol Metab199275109281400877
   PubMed Web of Science ®Google Scholar
• ThompsonIMGoodmanPJTangenCMThe influence of finasteride on the development of prostate cancerN Engl J Med20033492152412824459
   PubMed Web of Science ®Google Scholar
• TibblinGAdlerberthALindstedtGThe pituitary-gonadal axis and health in elderly men: a study of men born in 1913Diabetes199645160598866567
   PubMed Web of Science ®Google Scholar
• TremblayRRDubeJYPlasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptivesContraception1974105996054448070
   PubMed Web of Science ®Google Scholar
• TripathyDShahPLakshmyREffect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadismHorm Metab Res19983064259851674
   PubMed Web of Science ®Google Scholar
• TsaiECBoykoEJLeonettiDLLow serum testosterone level as a predictor of increased visceral fat in Japanese-American menInt J Obes Relat Metab Disord2000244859110805506
   PubMed Web of Science ®Google Scholar
• UrbanRJBodenburgYHGilkisonCTestosterone administration to elderly men increases skeletal muscle strength and protein synthesisAm J Physiol1995269E82067491931
   PubMed Web of Science ®Google Scholar
• van den BeldAWBotsMLJanssenJAEndogenous hormones and carotid atherosclerosis in elderly menAm J Epidemiol2003157253112505887
   PubMed Web of Science ®Google Scholar
• Van PottelberghIBraeckmanLDe BacquerDDifferential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged menAtherosclerosis20031669510212482555
   PubMed Web of Science ®Google Scholar
• VeldhuisJDUrbanRJDufauMLEvidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in menJ Clin Endocrinol Metab1992741227351592863
   PubMed Web of Science ®Google Scholar
• VermeulenAStoicaTVerdonckLThe apparent free testosterone concentration, an index of androgenicityJ Clin Endocrinol Metab197133759675125384
   PubMed Web of Science ®Google Scholar
• WangCAlexanderGBermanNTestosterone replacement therapy improves mood in hypogonadal men – a clinical research center studyJ Clin Endocrinol Metab1996813578838855804
   PubMed Web of Science ®Google Scholar
• WangCCunninghamGDobsALong-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal menJ Clin Endocrinol Metab20048920859815126525
   PubMed Web of Science ®Google Scholar
• WangCSwerdloffRKipnesMNew testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal menJ Clin Endocrinol Metab2004893821915292312
   PubMed Web of Science ®Google Scholar
• WebbCMAdamsonDLde ZeiglerDEffect of acute testosterone on myocardial ischemia in men with coronary artery diseaseAm J Cardiol1999834379A910072236
   PubMed Web of Science ®Google Scholar
• WebbCMMcNeillJGHaywardCSEffects of testosterone on coronary vasomotor regulation in men with coronary heart diseaseCirculation19991001690610525487
   PubMed Web of Science ®Google Scholar
• WHODefinition, Diagnosis and classification of Diabetes Mellitus1999GenevaWHO
   Google Scholar
• WuSZWengXZTherapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patientsChin Med J (Engl)1993106415188222891
   PubMed Web of Science ®Google Scholar
• YaffeKLuiLYZmudaJSex hormones and cognitive function in older menJ Am Geriatr Soc2002507071211982672
   PubMed Web of Science ®Google Scholar
• YesilovaZOzataMKocarIHThe effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadismJ Clin Endocrinol Metab200085667010634365
   PubMed Web of Science ®Google Scholar
• ZacharinMRPuaJKanumakalaSBone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadismClin Endocrinol (Oxf)200358691512780744
   PubMed Web of Science ®Google Scholar
• ZimmetPMaglianoDMatsuzawaYThe metabolic syndrome: a global public health problem and a new definitionJ Atheroscler Thromb20051229530016394610
   PubMed Web of Science ®Google Scholar
• ZitzmannMBruneMKornmannBThe CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy malesClin Endocrinol (Oxf)2001556495711894977
   PubMed Web of Science ®Google Scholar
• ZitzmannMDepenbuschMGromollJProstate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic studyJ Clin Endocrinol Metab20038820495412727953
   PubMed Web of Science ®Google Scholar
• ZitzmannMNieschlagEBehreHMAndrogens and erythropoiesisTestosterone. Action, deficiency, substitution2004CambridgeUniversity of Cambridge28396
   Google Scholar